It's the same show, just a different day. We've been here before. People in on the financing mitigate their risk as the share price pulls back to the financing price. We'll stabilize and yes, then we'll go back up as the trial marches on and we get additional indications added. The big plus for me this time is they've actually gotten nearly 8 million additional dollars through the warrants and I believe roughly another 10 million is to be had. Certainly creates an overhang temporarily but it will pass. Certainly no one can argue that with 30-40 million on the books we can't complete the current trial and start 2-3 additional indications and still have money in the bank for 2021 and 2022.
Market Data 
Markets 
AI
